Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.80 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.80 |
| ▸ | LMNA | P02545 | 1/20 | 0.80 |
| ▸ | MAPT | P10636 | 1/20 | 0.80 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.71 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.71 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.71 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.71 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.71 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.71 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.71 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.71 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.71 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.71 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.71 |
| ▸ | HSD17B3 | P37058 | 6/20 | 0.70 |
| ▸ | CES2 | O00748 | 2/20 | 0.68 |
| ▸ | CES1 | P23141 | 2/20 | 0.68 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | CASP3 | P42574 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL962630 | 1.00 | L3MBTL1 (0.80) | L3MBTL1TDP1LMNAMAPTHDAC8 | |
| SCHEMBL5439959 | 1.00 | L3MBTL1 (0.80) | L3MBTL1TDP1LMNAMAPTHDAC8 | |
| SCHEMBL965245 | 1.00 | L3MBTL1 (0.80) | L3MBTL1TDP1LMNAMAPTHDAC8 | |
| SCHEMBL5434100 | 1.00 | L3MBTL1 (0.80) | L3MBTL1TDP1LMNAMAPTHDAC8 | |
| SCHEMBL7889913 | 1.00 | L3MBTL1 (0.80) | L3MBTL1TDP1LMNAMAPTHDAC8 | |
| SCHEMBL8537813 | 1.00 | L3MBTL1 (0.80) | L3MBTL1TDP1LMNAMAPTHDAC8 | |
| SCHEMBL1330234 | 1.00 | L3MBTL1 (0.80) | L3MBTL1TDP1LMNAMAPTHDAC8 | |
| SCHEMBL967946 | 1.00 | L3MBTL1 (0.80) | L3MBTL1TDP1LMNAMAPTHDAC8 | |
| SCHEMBL22528986 | 1.00 | L3MBTL1 (0.80) | L3MBTL1TDP1LMNAMAPTHDAC8 | |
| SCHEMBL962848 | 1.00 | L3MBTL1 (0.80) | L3MBTL1TDP1LMNAMAPTHDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 527 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624308-B2 | Biodegradable delivery particles | ENCAPSYS, LLC (US) | 2026-05-12 | — | — | US | claimed |
| US-12624312-B2 | Fabric care composition with delivery particles | THE PROCTER & GAMBLE COMPANY (US) | 2026-05-12 | — | — | US | claimed |
| EP-4735520-A1 | COMPOSITIONS OF PLANT-BASED FLOUR DELIVERY PARTICLES | Encapsys, LLC (US) | 2026-05-06 | — | — | EP | claimed |
| US-12577510-B2 | Dryer sheet and process of making | THE PROCTER & GAMBLE COMPANY (US) | 2026-03-17 | — | — | US | claimed |
| US-20260071153-A1 | TREATMENT COMPOSITION WITH CHITOSAN-BASED DELIVERY PARTICLES | ENCAPSYS, LLC (US) | 2026-03-12 | — | — | US | claimed |
| EP-3890685-B1 | COMPOSITIONS COMPRISING BENEFIT AGENT CONTAINING DELIVERY PARTICLE | ENCAPSYS LLC (US) | 2026-03-11 | — | — | EP | claimed |
| US-12570910-B2 | Systems and methods for processing pyrolysis oil | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2026-03-10 | — | — | US | claimed |
| US-20250376643-A1 | TREATMENT COMPOSITION WITH PERFUME-CONTAINING DELIVERY PARTICLES | ENCAPSYS, LLC (US) | 2025-12-11 | — | — | US | claimed |
| US-20250367083-A1 | DEGRADABLE DELIVERY PARTICLES MADE FROM REDOX-INITIATOR-MODIFIED CHITOSAN | ENCAPSYS, LLC (US) | 2025-12-04 | — | — | US | claimed |
| US-12486478-B2 | Consumer products comprising delivery particles with high core:wall ratios | THE PROCTER & GAMBLE COMPANY (US) | 2025-12-02 | — | — | US | claimed |
| EP-1373339-B1 | SHAPE MEMORY STYRENE COPOLYMER | JOHNSON & JOHNSON VISION CARE (US) | 2006-01-18 | — | — | EP | claimed |
| JP-2004521172-A | — | — | 2004-07-15 | — | — | JP | claimed |
| US-6759481-B2 | Shape memory styrene copolymer | CORNERSTONE RESEARCH GROUP, INC. | 2004-07-06 | — | — | US | claimed |
| EP-1373339-A1 | SHAPE MEMORY STYRENE COPOLYMER | Johnson & Johnson Vision Care, Inc. (US) | 2004-01-02 | — | — | EP | claimed |
| US-6461417-B1 | Ink compositions | XEROX CORPORATION | 2002-10-08 | — | — | US | claimed |
| US-20020137864-A1 | Shape memory styrene copolymer | CORNERSTONE RESEARCH GROUP, INC. | 2002-09-26 | — | — | US | claimed |
| WO-2002059170-A1 | SHAPE MEMORY STYRENE COPOLYMER | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2002-08-01 | — | — | WO | claimed |
| US-5902390-A | Ink compositions containing ketones | XEROX CORPORATION (US) | 1999-05-11 | — | — | US | claimed |
| EP-0616262-A2 | Recording sheets | XEROX CORPORATION (US) | 1994-09-21 | — | — | EP | claimed |
| US-5302439-A | Electrography, offset printing; substrate with binder, additives, antistatic agents | XEROX CORPORATION (US) | 1994-04-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624308-B2 | Biodegradable delivery particles | SCD, FADS1, ACMSD | L3MBTL1 1808/4885TDP1 4689/4885LMNA 2638/4885 |
| US-12577510-B2 | Dryer sheet and process of making | SAMM50, MAT1A, NOS3 | L3MBTL1 1320/4885TDP1 435/4885LMNA 696/4885 |
| US-20260071153-A1 | TREATMENT COMPOSITION WITH CHITOSAN-BASED DELIVERY PARTICLES | CHIT1, MUC1, EXOSC10 | L3MBTL1 2018/4885TDP1 3824/4885LMNA 2675/4885 |
| US-12624312-B2 | Fabric care composition with delivery particles | HDAC3, HACD3, EXOSC4 | L3MBTL1 498/4885TDP1 1876/4885LMNA 266/4885 |
| US-12570910-B2 | Systems and methods for processing pyrolysis oil | SCO2, HAO2, ATXN2L | L3MBTL1 2929/4885TDP1 2875/4885LMNA 891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.